|1.||Zhao, Di: 2 articles (07/2009 - 07/2008)|
|2.||Navar, L Gabriel: 2 articles (07/2009 - 07/2008)|
|3.||Muir, Scott: 2 articles (11/2008 - 03/2006)|
|4.||Milia, Paolo: 2 articles (11/2008 - 03/2006)|
|5.||Alem, Manal: 2 articles (11/2008 - 03/2006)|
|6.||Lees, Kennedy: 2 articles (11/2008 - 03/2006)|
|7.||Walters, Matthew: 2 articles (11/2008 - 03/2006)|
|8.||Zarnke, Kelly B: 2 articles (04/2006 - 03/2006)|
|9.||Potter, John F: 2 articles (01/2005 - 10/2004)|
|10.||Panerai, Ronney B: 2 articles (01/2005 - 10/2004)|
|1.||Hypertension (High Blood Pressure)
10/15/1990 - "The object of this study was to determine the clinically relevant dose of bendrofluazide for the treatment of arterial hypertension. "
01/01/2011 - "Her hypertension was treated with bendroflumethiazide, which had been increased from 2.5 to 5 mg daily by her general practitioner about 18 months prior to her admission. "
10/15/1990 - "[The optimal dose of bendroflumethiazide in hypertension. "
04/14/1990 - "The relevant range of doses of bendrofluazide to treat mild to moderate hypertension is 1.25-2.5 mg a day. "
04/14/1990 - "To determine the relevant dose of bendrofluazide for treating mild to moderate hypertension. "
01/01/2005 - "Following acute ischaemic stroke, the standard dose of bendrofluazide at 2.5 mg daily in this study sample did not lower systemic BP levels over the subsequent 7-day period. "
01/01/2005 - "Thirty-seven hypertensive neuroradiologically proven ischaemic stroke patients were randomized in a double-blind, placebo controlled, parallel group study to bendrofluazide 2.5 mg daily or matching placebo, within 96 h of stroke onset, for a 7-day period. "
10/01/2004 - "Casual blood pressure levels were not significantly reduced in stroke patients with bendrofluazide, but in the placebo group levels increased by 13 +/- 13/6 +/- 7 mmHg (P < 0.001) at study termination. "
10/01/2004 - "In this study the effects of bendrofluazide on blood pressure levels and variability, dynamic cerebral autoregulation and cardiac baroreceptor sensitivity were assessed in the sub-acute stroke period. "
01/01/2005 - "Bendrofluazide appears to be an ineffective hypotensive agent at the standard dosage in the initial post-stroke period."
07/01/1961 - "Bendroflumethiazide diuresis in congestive heart failure."
01/01/1985 - "The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure. "
04/01/1993 - "Eight patients with mild heart failure were treated in random order for 1 week with 2 mg bumethanide at 0800 and 1200 (treatment 1) h, 1 mg bumethanide at 0800, 1200, 1800, 2200 (treatment 2) and 5 mg bendroflumethiazide at 0800 and 1800 (treatment 3) h. "
01/01/1985 - "It was concluded slow-release furosemide 30 mg or 60 mg daily was as effective as bendroflumethiazide 2.5 mg daily for maintenance treatment in mild to moderate congestive heart failure."
01/01/1985 - "Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure."
|4.||Hyperaldosteronism (Conn Syndrome)
|5.||Nephrogenic Diabetes Insipidus
03/01/2014 - "This study investigated whether the direct and indirect actions of bendroflumethiazide (BFTZ) simultaneously cooperated and also whether the renal nerves were involved in inducing long-term antidiuresis in nephrogenic diabetes insipidus (NDI). "
12/01/2010 - "This study examined how these two proposed mechanisms actually cooperate to induce an acute bendroflumethiazide (BFTZ)-antidiuretic effect in nephrogenic diabetes insipidus (NDI). "
10/01/2001 - "The mechanisms underlying the acute antidiuretic response to bendroflumethiazide (BFTZ; 0.25 mg/h for 3 h) in rats with nephrogenic diabetes insipidus (NDI) was investigated. "
03/01/2014 - "Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus."
12/01/2010 - "Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus."
|2.||Renal Dialysis (Hemodialysis)
|3.||Sodium-Restricted Diet (Diet, Sodium Restricted)